FORA Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-9,402
| Closed | -$4.37M | – | 610 |
|
2024
Q3 | $4.37M | Buy |
9,402
+1,229
| +15% | +$572K | 0.51% | 54 |
|
2024
Q2 | $3.83M | Buy |
8,173
+3,329
| +69% | +$1.56M | 0.47% | 70 |
|
2024
Q1 | $2.02M | Buy |
+4,844
| New | +$2.02M | 0.17% | 162 |
|
2023
Q4 | – | Sell |
-15,189
| Closed | -$5.28M | – | 658 |
|
2023
Q3 | $5.28M | Buy |
15,189
+11,257
| +286% | +$3.91M | 0.46% | 56 |
|
2023
Q2 | $1.38M | Buy |
+3,932
| New | +$1.38M | 0.2% | 134 |
|
2022
Q1 | – | Sell |
-5,909
| Closed | -$1.3M | – | 642 |
|
2021
Q4 | $1.3M | Sell |
5,909
-17
| -0.3% | -$3.73K | 0.5% | 49 |
|
2021
Q3 | $1.08M | Buy |
+5,926
| New | +$1.08M | 0.27% | 111 |
|
2021
Q2 | – | Sell |
-4,157
| Closed | -$893K | – | 1169 |
|
2021
Q1 | $893K | Buy |
+4,157
| New | +$893K | 0.29% | 71 |
|
2020
Q2 | – | Sell |
-3,741
| Closed | -$890K | – | 1344 |
|
2020
Q1 | $890K | Sell |
3,741
-8,253
| -69% | -$1.96M | 0.19% | 142 |
|
2019
Q4 | $2.63M | Buy |
+11,994
| New | +$2.63M | 0.26% | 87 |
|